| Date Filed | Type | Description |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/22/2022 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/12/2022 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 37,600 options to buy
@ $0.6, valued at
$22.6k
|
|
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/11/2020 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 14,634 options to buy
@ $8.8, valued at
$128.8k
|
|
| 05/04/2020 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $6, valued at
$60k
|
|
| 05/01/2020 |
4/A
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 03/03/2020 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $2.915, valued at
$43.7k
|
|
| 07/16/2019 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 227,330 options to buy
@ $5.39, valued at
$1.2M
|
|
| 07/16/2019 |
3
| GOLDSTEIN DOV A MD (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 03/15/2019 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 30,000 options to buy
@ $3.89, valued at
$116.7k
|
|
| 06/25/2018 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 17,500 options to buy
@ $4.91, valued at
$85.9k
|
|
| 06/08/2018 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Disposed of 5,000 shares
@ $0
Disposed of 8,000 shares
@ $0
Exercised 5,000 options to buy
@ $14.42, valued at
$72.1k
Exercised 8,000 options to buy
@ $17.75, valued at
$142k
|
|
| 05/25/2018 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 10,100 options to buy
@ $38.32, valued at
$387k
|
|
| 12/20/2017 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Disposed of 21,471 shares
@ $0
Exercised 21,471 options to buy
@ $3.7, valued at
$79.4k
|
|
| 12/08/2017 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Acquired 38 shares
@ $0 |
|
| 06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 07/25/2012 |
4
| GOLDSTEIN DOV A MD (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc. |
| 04/05/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/23/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|